Company Results (links open in a new window)
|
Date (document was filed at Companies House)
|
Type
|
Description (of the document filed at Companies House)
|
View / Download (PDF file, link opens in new window)
|
|
06 Nov 2024 |
CH01 |
Director's details changed for Mr Lewis Campbell on 6 November 2024
|
|
|
24 Sep 2024 |
CS01 |
Confirmation statement made on 24 September 2024 with no updates
|
|
|
05 Jul 2024 |
AA |
Full accounts made up to 31 December 2023
|
|
|
20 Feb 2024 |
RP04CS01 |
Second filing of Confirmation Statement dated 24 September 2022
|
|
|
05 Feb 2024 |
PSC05 |
Change of details for Target Healthcare Group Limited as a person with significant control on 6 July 2022
|
|
|
26 Sep 2023 |
CS01 |
Confirmation statement made on 24 September 2023 with no updates
|
|
|
09 Jun 2023 |
AA |
Full accounts made up to 31 December 2022
|
|
|
28 Sep 2022 |
AA |
Full accounts made up to 31 December 2021
|
|
|
26 Sep 2022 |
CS01 |
Confirmation statement made on 24 September 2022 with no updates
-
ANNOTATION
Clarification a second filed CS01 (capital and shareholders details) was registered on 20/02/2024.
|
|
|
15 Sep 2022 |
AP01 |
Appointment of Mrs Gillian Grant as a director on 23 August 2022
|
|
|
22 Aug 2022 |
PSC02 |
Notification of Target Healthcare Group Limited as a person with significant control on 6 July 2022
|
|
|
22 Aug 2022 |
PSC07 |
Cessation of Target Healthcare Limited as a person with significant control on 6 July 2022
|
|
|
30 May 2022 |
TM01 |
Termination of appointment of David Alan Sanson as a director on 30 May 2022
|
|
|
21 Feb 2022 |
MR04 |
Satisfaction of charge 052403040015 in full
|
|
|
21 Feb 2022 |
MR04 |
Satisfaction of charge 052403040014 in full
|
|
|
21 Feb 2022 |
MR04 |
Satisfaction of charge 052403040013 in full
|
|
|
11 Feb 2022 |
MR01 |
Registration of charge 052403040016, created on 3 February 2022
|
|
|
25 Oct 2021 |
CS01 |
Confirmation statement made on 24 September 2021 with updates
|
|
|
22 Jul 2021 |
AA01 |
Current accounting period extended from 30 June 2021 to 31 December 2021
|
|
|
14 Jul 2021 |
SH08 |
Change of share class name or designation
|
|
|
14 Jul 2021 |
AA01 |
Current accounting period shortened from 30 June 2022 to 31 December 2021
|
|
|
14 Jul 2021 |
AP01 |
Appointment of Mr David Alan Sanson as a director on 14 July 2021
|
|
|
14 Jul 2021 |
AP01 |
Appointment of Mr Stephen Peter Duncan as a director on 14 July 2021
|
|
|
07 Jul 2021 |
TM01 |
Termination of appointment of David Alan Sanson as a director on 30 June 2021
|
|
|
07 Jul 2021 |
PSC07 |
Cessation of Quantum Pharma Group Limited as a person with significant control on 30 June 2021
|
|